The 14th Annual Meeting of the Oligonucleotide Therapeutics Society

Join leading experts in the field for the OTS Annual Meeting which will feature the latest developments from the various oligonucleotide-based disciplines.

Session Topics Include:
RNAi
Antisense
mRNA
CRISPR
miRNA
Aptamers
Delivery
Chemistry
Safety

Abstract Submission Deadlines:
July 9, 2018 – Short Talks, Awards & Travel Grants
August 6, 2018 – Poster Presentations

Committee Chair:

Steve F. Dowdy, PhD, UCSD School of Medicine

Organizing Committee:

Annemieke Aartsma-Rus, PhD, Leiden University Medical Center
David Corey, PhD, UT Southwestern
Masad Damha, PhD, FCIC, McGill University
Richard Geary, PhD, Ionis Pharmaceuticals, Inc.
Mark Kay, MD, PhD, Stanford University
Anastasia Khvorova, PhD, RNA Therapeutics Institute, UMass Medical School
Matthew Levy, PhD, Vitrisa Therapeutics
Marc Lemaitre, PhD, ML_Consult
Art Levin, PhD, Avidity Biosciences
Mano Manoharan, PhD, Alnylam Pharmaceuticals
Melissa J. Moore, PhD, Moderna Therapeutics
Laura Sepp-Lorenzino, PhD, Vertex Pharmaceuticals, Inc.
Takanori Yokota, PhD, Tokyo Medical and Dental University

More Information:  https://www.oligotherapeutics.org/2018-annual-meeting/